The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as 'ecstasy,' to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.
New MDMA variants identified for potentially safer psychotherapeutic use retrieved 25 June 2024 from https://medicalxpress.com/news/2024-06-mdma-variants-potentially-safer-psychotherapeutic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New MDMA variants could be promising alternatives for safe psychotherapeutic applicationsThe use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as 'ecstasy', to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.
Read more »
New name, new uniform and new principal at Telford secondary schoolA Telford secondary school has announced the start of an ambitious new era – with a new name, new uniform, and a new principal.
Read more »
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationFederal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD—part of a decadeslong effort by psychedelic advocates to win medical acceptance for the drug's purported benefits.
Read more »
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocatesA first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday—a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical mainstream.
Read more »
FDA Advisors Recommend Against Using MDMA for PTSD TreatmentA panel of experts advising the U.S. Food and Drug Administration voted against using MDMA as a treatment for post-traumatic stress disorder.
Read more »
Doctors investigate after woman, 41, ‘cures agonising long Covid with magic mushrooms and MDMA’...Magic mushrooms could ‘cure depression’ within three years, experts say
Read more »